# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-26-023210
Filing Date
2026-05-14
Accepted
2026-05-14 17:30:07
Documents
72
Period of Report
2026-03-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | form10-q.htm iXBRL | 10-Q | 2572804
2 | EX-31.1 | ex31-1.htm | EX-31.1 | 31821
3 | EX-32.1 | ex32-1.htm | EX-32.1 | 13936
| Complete submission text file | 0001493152-26-023210.txt |  | 11714317

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
4 | XBRL SCHEMA FILE | ppcb-20260331.xsd | EX-101.SCH | 69615
5 | XBRL CALCULATION FILE | ppcb-20260331_cal.xml | EX-101.CAL | 75463
6 | XBRL DEFINITION FILE | ppcb-20260331_def.xml | EX-101.DEF | 358664
7 | XBRL LABEL FILE | ppcb-20260331_lab.xml | EX-101.LAB | 574936
8 | XBRL PRESENTATION FILE | ppcb-20260331_pre.xml | EX-101.PRE | 472352
75 | EXTRACTED XBRL INSTANCE DOCUMENT | form10-q_htm.xml | XML | 1671484

Mailing Address 302/6 BUTLER STREET CAMBERWELL, VICTORIA C3 3124
Business Address 302/6 BUTLER STREET CAMBERWELL, VICTORIA C3 3124 61-03-9882-0780
Propanc Biopharma, Inc. (Filer) CIK: 0001517681 (see all company filings)

EIN.: 330662986 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 001-42806 | Film No.: 26980669
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)